Dec 5 (Reuters) - Medical device maker Insulet (PODD.O) convinced a jury that Korean rival EOFlow (294090.KQ) owes it $452 million in damages for stealing trade secrets related to insulin pumps
Both the local and central divisions in Milan have rejected Insulet's PI applications due to doubts about the validity of the patent-in-suit. This is a setback in the company's fight over insulin
total 1 pages, 2 items